Comparative results of the mitogenic effects of polyclonal B-cell activators in different stages of chronic lymphocytic leukemia.
D001402:B-Lymphocytes / Q000276:immunology*; D006801:Humans; D007945:Leukemia, Lymphoid / Q000276:immunology* / Q000473:pathology; D008070:Lipopolysaccharides / Q000276:immunology; D008213:Lymphocyte Activation; D009367:Neoplasm Staging; D010835:Phytohemagglutinins; D013211:Staphylococcus aureus / Q000276:immunology; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D008070:Lipopolysaccharides; D010835:Phytohemagglutinins; C047876:phytohemagglutinin-M; D013755:Tetradecanoylphorbol Acetate